Feature|Podcasts|October 25, 2024
Fake Weight Loss Drugs: Growing Threat to Consumer Health
Author(s)Miranda Schmalfuhs
In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
Advertisement
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:
- Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks
- What can be done to raise awareness among consumers about the dangers of counterfeit medications
- Ways increase access to legitimate weight loss medications, especially for those in underserved communities
- and much more!
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMD Serono Announces Agreement with Trump Administration Increasing Access to In Vitro Fertilization Therapies for US Patients
2
What Impact will TrumpRx and Other DTC Programs Have on Drug Availability?
3
Eli Lilly’s and Novo’s Stocks React to President Trump’s Comments on GLP-1 Prices
4
All of the Medications Announced as Part of FDA’s National Priority Voucher Program
5
